EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

F Roth-Walter iD, I M Adcock iD, C Benito-Villalvilla iD, R Bianchini iD, L Bjermer iD, G Caramori iD, L Cari iD, K F Chung iD, Z Diamant iD, I Eguiluz-Gracia iD, E F Knol iD, M Jesenak iD and 8 more

Allergy · 2024-05 · 79 (5) · 1089-1122

DOI: 10.1111/all.15977 ↗

At a glance

Übersichtsarbeit in Allergy, published online on 2023-12-18. Written by F Roth-Walter and 19 co-authors. Institution: Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and …. Major MEDLINE topics: Cellular Senescence, Metabolic Networks and Pathways. Cited 30 times so far (Crossref); 396 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Aimwell Charitable Trust, Austrian Science Fund FWF project SFB F4606-B28, Danube Allergy Research Cluster-DARC #08.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The accumulation of senescent cells drives inflammaging and increases morbidity of chronic inflammatory lung diseases. Immune responses are built upon dynamic changes in cell metabolism that supply energy and substrates for cell proliferation, differentiation, and activation. Metabolic changes imposed by environmental stress and inflammation on immune cells and tissue microenvironment are thus chiefly involved in the pathophysiology of allergic and other immune‐driven diseases. Altered cell metabolism is also a hallmark of cell senescence, a condition characterized by loss of proliferative activity in cells that remain metabolically active. Accelerated senescence can be triggered by acute or chronic stress and inflammatory responses. In contrast, replicative senescence occurs as part of the physiological aging process and has protective roles in cancer surveillance and wound healing. Importantly, cell senescence can also change or hamper response to diverse therapeutic treatments. Understanding the metabolic pathways of senescence in immune and structural cells is therefore critical to detect, prevent, or revert detrimental aspects of senescence‐related immunopathology, by developing specific diagnostics and targeted therapies. In this paper, we review the main changes and metabolic alterations occurring in senescent immune cells (macrophages, B cells, T cells). Subsequently, we present the metabolic footprints described in translational studies in patients with chronic asthma and chronic obstructive pulmonary disease (COPD), and review the ongoing preclinical studies and clinical trials of therapeutic approaches aiming at targeting metabolic pathways to antagonize pathological senescence. Because this is a recently emerging field in allergy and clinical immunology, a better understanding of the metabolic profile of the complex landscape of cell senescence is needed. The progress achieved so far is already providing opportunities for new therapies, as well as for strategies aimed at disease prevention and supporting healthy aging.

Subjects

MeSH terms (MEDLINE)

Cellular SenescenceMetabolic Networks and PathwaysHumansAnimalsChronic DiseaseInflammationLung DiseasesPulmonary Disease, Chronic ObstructiveAging

Author keywords

cell metabolismimmune senescenceimmunometabolisminflammagingsenolytic drugssenomorphic drugs

Authors and institutions

  • Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria.
  • Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Molecular Cell Biology Group, National Heart & Lung Institute, Imperial College London, London, UK.
  • Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain.
  • Department of Respiratory Medicine and Allergology, Lung and Allergy research, Allergy, Asthma and COPD Competence Center, Lund University, Lund, Sweden.
  • Department of Medicine and Surgery, University of Parma, Pneumologia, Italy.

ORCID profiles: F Roth-Walter, I M Adcock, C Benito-Villalvilla, R Bianchini, L Bjermer, G Caramori, L Cari, K F Chung, Z Diamant, I Eguiluz-Gracia, E F Knol, M Jesenak, F Levi-Schaffer, G Nocentini, L O'Mahony, O Palomares, F Redegeld, M Sokolowska, B C A M Van Esch, C Stellato

Funding

  • Aimwell Charitable Trust
  • Austrian Science Fund FWF project SFB F4606-B28
  • Danube Allergy Research Cluster-DARC #08
  • Emalie Gutterman Memorial Endowed Fund
  • EPSRC (EP/T003189/1)
  • European Academy for Allergy and Clinical Immunology
  • Instituto de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness
  • Israel Science Foundation

Cite

APA

Roth-Walter, F., Adcock, I. M., Benito-Villalvilla, C., Bianchini, R., Bjermer, L., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguiluz-Gracia, I., Knol, E. F., Jesenak, M., Levi-Schaffer, F., Nocentini, G., O'Mahony, L., Palomares, O., Redegeld, F., Sokolowska, M., Van Esch, B. C. A. M., & Stellato, C. (2024). Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology. Allergy, 79(5), 1089-1122. https://doi.org/10.1111/all.15977

Vancouver

Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Caramori G, et al. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology. Allergy. 2024;79(5):1089-1122. doi:10.1111/all.15977

BibTeX
@article{RothWalter2024,
  author = {Roth-Walter, F and Adcock, I M and Benito-Villalvilla, C and Bianchini, R and Bjermer, L and Caramori, G and Cari, L and Chung, K F and Diamant, Z and Eguiluz-Gracia, I and Knol, E F and Jesenak, M and Levi-Schaffer, F and Nocentini, G and O'Mahony, L and Palomares, O and Redegeld, F and Sokolowska, M and Van Esch, B C A M and Stellato, C},
  title = {Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {5},
  pages = {1089--1122},
  doi = {10.1111/all.15977}
}
Start for free →